Skip to main content
logo
Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
60.85
-4.68 (-7.14%)
At close: Mar 30, 2026, 4:00 PM EDT
61.85
+1.00 (1.64%)
After-hours: Mar 30, 2026, 7:34 PM EDT

Veradermics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
-53.0816.3
Cash & Short-Term Investments
15.1453.0816.3
Cash Growth
-71.48%225.75%-
Other Receivables
-1.38-
Receivables
-1.38-
Prepaid Expenses
-1.041.22
Other Current Assets
-0.040.05
Total Current Assets
-55.5417.56
Total Assets
-55.5417.56
Accounts Payable
-2.251.85
Accrued Expenses
-2.471.2
Total Current Liabilities
-4.723.05
Long-Term Debt
--0.79
Total Liabilities
-4.723.84
Common Stock
-00
Additional Paid-In Capital
-0.750.5
Retained Earnings
--49.23-22.74
Comprehensive Income & Other
--3.85-0.89
Total Common Equity
-98.48-52.33-23.14
Shareholders' Equity
13.0950.8213.72
Total Liabilities & Equity
-55.5417.56
Total Debt
0.02-0.79
Net Cash (Debt)
15.1253.0815.51
Net Cash Growth
-71.51%242.26%-
Net Cash Per Share
20.1972.0321.05
Filing Date Shares Outstanding
0.750.740.74
Total Common Shares Outstanding
0.750.740.74
Working Capital
-50.8214.51
Book Value Per Share
-131.48-71.01-31.39
Tangible Book Value
-98.48-52.33-23.14
Tangible Book Value Per Share
-131.48-71.01-31.39
Updated Jan 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q